Current State of the Art in Ventricle Tissue Engineering

Overview

Journal Front Cardiovasc Med

Specialty Cardiology & Vascular Diseases

Date 2020 Nov 26

PMID 33240941

Citations 2

Authors

Ravi K Birla

Affiliations

Soon will be listed here.

Abstract

The field of ventricle tissue engineering is focused on bioengineering highly functioning left ventricles that can be used as model systems for basic cardiology research and for cardiotoxicity testing. In this article, we review the current state of the art in the field of ventricle tissue engineering and discuss different strategies that have been used to bioengineer ventricles. Based on this body of literature, there are now common themes in the field that provide guidance for future directives, also presented in this article.

Citing Articles

Development of Novel 3D Spheroids for Discrete Subaortic Stenosis.

Brimmer S, Ji P, Birla R, Heinle J, Grande-Allen J, Keswani S Cardiovasc Eng Technol. 2024; 15(6):704-715.

PMID: 39495395 DOI: 10.1007/s13239-024-00746-x.

Recent advances in biological pumps as a building block for bioartificial hearts.

Brimmer S, Ji P, Birla A, Keswani S, Caldarone C, Birla R Front Bioeng Biotechnol. 2023; 11:1061622.

PMID: 36741765 PMC: 9895798. DOI: 10.3389/fbioe.2023.1061622.

References

Birla R, Huang Y, Dennis R . Development of a novel bioreactor for the mechanical loading of tissue-engineered heart muscle. Tissue Eng. 2007; 13(9):2239-48. DOI: 10.1089/ten.2006.0359. View

Patel N, Birla R . The Bioengineered Cardiac Left Ventricle. ASAIO J. 2017; 64(1):56-62. DOI: 10.1097/MAT.0000000000000642. View

Markou M, Kouroupis D, Badounas F, Katsouras A, Kyrkou A, Fotsis T . Tissue Engineering Using Vascular Organoids From Human Pluripotent Stem Cell Derived Mural Cell Phenotypes. Front Bioeng Biotechnol. 2020; 8:278. PMC: 7182037. DOI: 10.3389/fbioe.2020.00278. View

Li R, Keung W, Cashman T, Backeris P, Johnson B, Bardot E . Bioengineering an electro-mechanically functional miniature ventricular heart chamber from human pluripotent stem cells. Biomaterials. 2018; 163:116-127. PMC: 6561506. DOI: 10.1016/j.biomaterials.2018.02.024. View

Zhang Y, Arneri A, Bersini S, Shin S, Zhu K, Goli-Malekabadi Z . Bioprinting 3D microfibrous scaffolds for engineering endothelialized myocardium and heart-on-a-chip. Biomaterials. 2016; 110:45-59. PMC: 5198581. DOI: 10.1016/j.biomaterials.2016.09.003. View

Patel N, Birla R . Pulsatile flow conditioning of three-dimensional bioengineered cardiac ventricle. Biofabrication. 2016; 9(1):015003. DOI: 10.1088/1758-5090/9/1/015003. View

MacQueen L, Sheehy S, Chantre C, Zimmerman J, Pasqualini F, Liu X . A tissue-engineered scale model of the heart ventricle. Nat Biomed Eng. 2019; 2(12):930-941. PMC: 6774355. DOI: 10.1038/s41551-018-0271-5. View

Lee W, Hong Y, Dai G . 3D bioprinting of vascular conduits for pediatric congenital heart repairs. Transl Res. 2019; 211:35-45. PMC: 6702035. DOI: 10.1016/j.trsl.2019.03.007. View

Birla R, Williams S . 3D bioprinting and its potential impact on cardiac failure treatment: An industry perspective. APL Bioeng. 2020; 4(1):010903. PMC: 7028435. DOI: 10.1063/1.5128371. View

10.

Noor N, Shapira A, Edri R, Gal I, Wertheim L, Dvir T . 3D Printing of Personalized Thick and Perfusable Cardiac Patches and Hearts. Adv Sci (Weinh). 2019; 6(11):1900344. PMC: 6548966. DOI: 10.1002/advs.201900344. View

11.

Pomeroy J, Helfer A, Bursac N . Biomaterializing the promise of cardiac tissue engineering. Biotechnol Adv. 2019; 42:107353. PMC: 6702110. DOI: 10.1016/j.biotechadv.2019.02.009. View

12.

Andriotis E, Eleftheriadis G, Karavasili C, Fatouros D . Development of Bio-Active Patches Based on Pectin for the Treatment of Ulcers and Wounds Using 3D-Bioprinting Technology. Pharmaceutics. 2020; 12(1). PMC: 7023266. DOI: 10.3390/pharmaceutics12010056. View

13.

Hasan A, Saliba J, Modarres H, Bakhaty A, Nasajpour A, Mofrad M . Micro and nanotechnologies in heart valve tissue engineering. Biomaterials. 2016; 103:278-292. DOI: 10.1016/j.biomaterials.2016.07.001. View

14.

Patel N, Yazdi I, Tasciotti E, Birla R . Optimizing cell seeding and retention in a three-dimensional bioengineered cardiac ventricle: The two-stage cellularization model. Biotechnol Bioeng. 2016; 113(10):2275-85. DOI: 10.1002/bit.25992. View

15.

Stower H . Bioprinting a human heart. Nat Med. 2019; 25(9):1330. DOI: 10.1038/s41591-019-0585-1. View

16.

Maiullari F, Costantini M, Milan M, Pace V, Chirivi M, Maiullari S . A multi-cellular 3D bioprinting approach for vascularized heart tissue engineering based on HUVECs and iPSC-derived cardiomyocytes. Sci Rep. 2018; 8(1):13532. PMC: 6131510. DOI: 10.1038/s41598-018-31848-x. View

17.

Vacanti J, Morse M, Saltzman W, Domb A, Langer R . Selective cell transplantation using bioabsorbable artificial polymers as matrices. J Pediatr Surg. 1988; 23(1 Pt 2):3-9. DOI: 10.1016/s0022-3468(88)80529-3. View

18.

Tao Z, Mohamed M, Hogan M, Salazar B, Patel N, Birla R . Establishing the Framework for Fabrication of a Bioartificial Heart. ASAIO J. 2015; 61(4):429-36. DOI: 10.1097/MAT.0000000000000233. View

19.

Blan N, Birla R . Design and fabrication of heart muscle using scaffold-based tissue engineering. J Biomed Mater Res A. 2007; 86(1):195-208. DOI: 10.1002/jbm.a.31642. View

20.

Aslan A, Allahverdiyev A, Bagirova M, Abamor E . Problems in Stem Cell Therapy for Cardiac Repair and Tissue Engineering Approaches Based on Graphene and Its Derivatives. Curr Stem Cell Res Ther. 2018; 13(6):447-457. DOI: 10.2174/1574888X13666180510110055. View